CVE:NTB Neptune Technologies & Bioressources Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Neptune Technologies & Bioressources Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume31,049 shsAverage Volume315,395 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileChartEarningsInsider TradesHeadlinesSocial Media Neptune Technologies & Bioressources Inc. (Neptune) is a biotechnology company. The Company is engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The Company operates in three segments: Neptune, Acasti Pharma Inc. and Acasti Pharma Inc. Its Neptune produces and commercializes nutraceutical products. Its Acasti Pharma Inc. develops and commercializes pharmaceutical applications for cardiovascular diseases. Its NeuroBioPharm Inc. develops and commercializes pharmaceutical applications for neurological diseases. It produces omega-3 PUFAs through its patented process of extracting oils from Antartic krill, which omega-3 PUFAs are then principally sold as bulk oil to Neptune's distributors who commercialize them under their private label primarily in the United States, European and Australian nutraceutical markets. The Company's products include Neptune Krill Oil (NKO) and ECOKRILL Oil (EKO).Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Neptune Technologies & Bioressources. Previous Next 2.5 Community Rank Outperform VotesNeptune Technologies & Bioressources has received 45 “outperform” votes. (Add your “outperform” vote.)Underperform VotesNeptune Technologies & Bioressources has received 45 “underperform” votes. (Add your “underperform” vote.)Community SentimentNeptune Technologies & Bioressources has received 50.00% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Neptune Technologies & Bioressources and other stocks. Vote “Outperform” if you believe NTB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NTB will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldNeptune Technologies & Bioressources does not currently pay a dividend.Dividend GrowthNeptune Technologies & Bioressources does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Neptune Technologies & Bioressources insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.50 out of 5 stars Industry, Sector and Symbol Stock Exchange CVE Industry N/A Sub-IndustryN/A SectorN/A Current SymbolCVE:NTB Previous Symbol CUSIPN/A CIKN/A Webneptunekrilloil.com Phone+1-450-6872262Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable 30 days | 90 days | 365 days | Advanced Chart Receive NTB News and Ratings via Email Sign-up to receive the latest news and ratings for NTB and its competitors with MarketBeat's FREE daily newsletter. Neptune Technologies & Bioressources (CVE:NTB) Frequently Asked Questions How were Neptune Technologies & Bioressources' earnings last quarter? Neptune Technologies & Bioressources Inc (CVE:NTB) posted its earnings results on Tuesday, July, 15th. The biotechnology company reported ($0.06) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.08) by $0.02. The biotechnology company had revenue of $3.69 million for the quarter, compared to analyst estimates of $7.31 million. View Neptune Technologies & Bioressources' earnings history. What other stocks do shareholders of Neptune Technologies & Bioressources own? Based on aggregate information from My MarketBeat watchlists, some companies that other Neptune Technologies & Bioressources investors own include ACADIA Pharmaceuticals (ACAD), Adverum Biotechnologies (ADVM), Aimmune Therapeutics (AIMT), ANI Pharmaceuticals (ANIP), AxoGen (AXGN), Biohaven Pharmaceutical (BHVN), bluebird bio (BLUE), Blueprint Medicines (BPMC), Calithera Biosciences (CALA) and Codexis (CDXS). Who are Neptune Technologies & Bioressources' key executives? Neptune Technologies & Bioressources' management team includes the following people: John Moretz, Chairman of the BoardJames Stuart Hamilton, President, Chief Executive Officer, DirectorMario Paradis, Chief Financial OfficerMichel Timperio, Senior Vice President of Sales - Global SalesPierre Lemieux Ph.D., Chief Operating Officer of AcastiJean-Daniel Belanger, Corporate Secretary and Director - Corporate AffairsHarlan W. Waksal M.D., Director (Age 61)Valier Boivin, Independent DirectorRonald Denis, Independent DirectorAdrian Taylor Montgomery, Independent Director What is Neptune Technologies & Bioressources' stock symbol? Neptune Technologies & Bioressources trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NTB." How do I buy shares of Neptune Technologies & Bioressources? Shares of NTB and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is Neptune Technologies & Bioressources' official website? The official website for Neptune Technologies & Bioressources is neptunekrilloil.com. How can I contact Neptune Technologies & Bioressources? Neptune Technologies & Bioressources' mailing address is 545 Prom du Centropolis Suite 100, LAVAL, QC H7T 0A3, Canada. The biotechnology company can be reached via phone at +1-450-6872262. This page was last updated on 9/29/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
